Clovis Oncology, Inc.
CLVSDelisted Dec 29, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001466301
Clovis Oncology, Inc. was delisted on Dec 29, 2022; its insiders filed their last Form 4 on Nov 3, 2022; 103 institutions reported holding it in 13F filings for Q3 2022, worth $42.6M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Clovis Oncology, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CLVS is no longer listed, and 13F filings after Q3 2022 list far fewer holders. See Q3 2022
- Institutional holders
- 1
- +1 vs. Q2 2023
- Shares held
- 229
- +229 vs. Q2 2023
- Total value
- $11.0K
- +$11.0K vs. Q2 2023
- New holders
- 1
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $11.0K |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 2 | $520.2K |
| Q4 2022 | 15 | $20.1K |
| Q3 2022 | 103 | $42.6M |
| Q2 2022 | 116 | $76.0M |
| Q1 2022 | 153 | $111.7M |
| Q4 2021 | 154 | $176.8M |
| Q3 2021 | 159 | $274.0M |
| Q2 2021 | 161 | $319.9M |
| Q1 2021 | 165 | $347.3M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Clovis Oncology, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11.0K | 0.00% | +229 | New |